Last 12 months
Inside the activity.
0 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 27, 2021 Filed Feb 2, 2021 00:29 UTC |
Avelar RuiSee Remarks
|
GrantCommon Stock | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-21-000018 · wf-form4_161222574461892.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,103 F1 · price: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 27, 2021, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 27, 2021 Filed Feb 2, 2021 00:29 UTC |
SILVERNAIL LAUREN PSee Remarks
|
GrantCommon Stock | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-21-000019 · wf-form4_161222577187164.xml · nonDerivative · entry 1 SILVERNAIL LAUREN P · CIK 0001225755 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,689 F1 · price: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 27, 2021, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 27, 2021 Filed Feb 2, 2021 00:30 UTC |
Jafar Michael M.See Remarks
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-21-000020 · wf-form4_161222579548673.xml · nonDerivative · entry 1 Jafar Michael M. · CIK 0001744242 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,851 F1 · price: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 27, 2021, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 27, 2021 Filed Feb 2, 2021 00:29 UTC |
MOATAZEDI DAVIDDirector · See Remarks
|
GrantCommon Stock | 266,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-21-000017 · wf-form4_161222572441823.xml · nonDerivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,427 F1 · price: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 27, 2021, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 01:50 UTC |
Avelar RuiSee Remarks
|
SaleCommon Stock | 2,699 | $7.46 | $20,134.54 |
DisclosureSEC source: 0001570562-21-000010 · wf-form4_161171222211564.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,103 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in the first quarter of 2020 and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 01:51 UTC |
SILVERNAIL LAUREN PSee Remarks
|
SaleCommon Stock | 2,699 | $7.46 | $20,134.54 |
DisclosureSEC source: 0001570562-21-000012 · wf-form4_161171225932694.xml · nonDerivative · entry 1 SILVERNAIL LAUREN P · CIK 0001225755 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,689 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in the first quarter of 2020 and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 01:50 UTC |
Jafar Michael M.See Remarks
|
SaleCommon Stock | 2,699 | $7.46 | $20,134.54 |
DisclosureSEC source: 0001570562-21-000011 · wf-form4_161171223808786.xml · nonDerivative · entry 1 Jafar Michael M. · CIK 0001744242 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,851 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in the first quarter of 2020 and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 01:50 UTC |
MOATAZEDI DAVIDDirector · See Remarks
|
SaleCommon Stock | 8,310 | $7.46 | $61,992.60 |
DisclosureSEC source: 0001570562-21-000009 · wf-form4_161171220703468.xml · nonDerivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,760 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in the first quarter of 2020 and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. Read SEC document |
| October 28, 2020 Filed Oct 31, 2020 00:03 UTC |
Jafar Michael M.See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 79,350 | $0.00 Strike: $3.09 | $0.00 |
DisclosureSEC source: 0001570562-20-000124 · wf-form4_160410257452752.xml · derivative · entry 2 Jafar Michael M. · CIK 0001744242 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,350 Underlying: Common Stock · 79,350 shares Expires 2030-10-28 F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of October 28, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| October 28, 2020 Filed Oct 31, 2020 00:03 UTC |
Jafar Michael M.See Remarks
|
GrantCommon Stock | 48,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-20-000124 · wf-form4_160410257452752.xml · nonDerivative · entry 1 Jafar Michael M. · CIK 0001744242 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,550 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of October 28, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| May 13, 2020 Filed May 16, 2020 00:00 UTC |
Avelar RuiSee Remarks
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-20-000094 · wf-form4_158958718809777.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,802 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 100% of the award on July 1, 2021, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| May 13, 2020 Filed May 15, 2020 23:59 UTC |
SILVERNAIL LAUREN PSee Remarks
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-20-000093 · wf-form4_158958716608299.xml · nonDerivative · entry 1 SILVERNAIL LAUREN P · CIK 0001225755 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,388 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 100% of the award on July 1, 2021, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| May 13, 2020 Filed May 16, 2020 00:00 UTC |
Jafar Michael M.Chief Marketing Officer
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-20-000095 · wf-form4_158958721207647.xml · nonDerivative · entry 1 Jafar Michael M. · CIK 0001744242 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,000 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 100% of the award on July 1, 2021, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| May 13, 2020 Filed May 15, 2020 23:59 UTC |
MOATAZEDI DAVIDDirector · See Remarks
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-20-000092 · wf-form4_158958714451865.xml · nonDerivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,070 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 100% of the award on July 1, 2021, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 24, 2020 21:07 UTC |
GILL DAVID NDirector
|
GrantStock Option (Right to Buy) · Derivative | 23,458 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0001570562-20-000038 · wf-form4_157991805639271.xml · derivative · entry 1 GILL DAVID N · CIK 0001106519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,458 Underlying: Common Stock · 23,458 shares Expires 2030-01-23 F1 · derivative.exercise_date: The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 25, 2020 02:15 UTC |
Avelar RuiSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0001570562-20-000049 · wf-form4_157991848930412.xml · derivative · entry 2 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2030-01-23 F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 25, 2020 02:15 UTC |
Avelar RuiSee Remarks
|
GrantCommon Stock | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-20-000049 · wf-form4_157991848930412.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,802 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 24, 2020 21:07 UTC |
HAYMAN ROBERTDirector
|
GrantStock Option (Right to Buy) · Derivative | 23,458 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0001570562-20-000037 · wf-form4_157991803386903.xml · derivative · entry 1 HAYMAN ROBERT · CIK 0001269349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,458 Underlying: Common Stock · 23,458 shares Expires 2030-01-23 F1 · derivative.exercise_date: The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 25, 2020 02:06 UTC |
FARRELL PETER CDirector
|
GrantStock Option (Right to Buy) · Derivative | 23,458 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0001570562-20-000035 · wf-form4_157991798760151.xml · derivative · entry 1 FARRELL PETER C · CIK 0001186102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,458 Underlying: Common Stock · 23,458 shares Expires 2030-01-23 F1 · derivative.exercise_date: The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 25, 2020 02:14 UTC |
SILVERNAIL LAUREN PSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0001570562-20-000048 · wf-form4_157991846794918.xml · derivative · entry 2 SILVERNAIL LAUREN P · CIK 0001225755 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2030-01-23 F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 25, 2020 02:14 UTC |
SILVERNAIL LAUREN PSee Remarks
|
GrantCommon Stock | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-20-000048 · wf-form4_157991846794918.xml · nonDerivative · entry 1 SILVERNAIL LAUREN P · CIK 0001225755 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,388 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 24, 2020 21:14 UTC |
BLANK SIMONEDirector
|
GrantStock Option (Right to Buy) · Derivative | 23,458 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0001570562-20-000046 · wf-form4_157991842431171.xml · derivative · entry 1 BLANK SIMONE · CIK 0001366840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,458 Underlying: Common Stock · 23,458 shares Expires 2030-01-23 F1 · derivative.exercise_date: The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 25, 2020 02:15 UTC |
Jafar Michael M.Chief Marketing Officer
|
GrantStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0001570562-20-000050 · wf-form4_157991851086596.xml · derivative · entry 2 Jafar Michael M. · CIK 0001744242 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2030-01-23 F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 25, 2020 02:15 UTC |
Jafar Michael M.Chief Marketing Officer
|
GrantCommon Stock | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-20-000050 · wf-form4_157991851086596.xml · nonDerivative · entry 1 Jafar Michael M. · CIK 0001744242 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,000 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 25, 2020 02:14 UTC |
MOATAZEDI DAVIDDirector · See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 141,910 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0001570562-20-000047 · wf-form4_157991844635493.xml · derivative · entry 2 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,910 Underlying: Common Stock · 141,910 shares Expires 2030-01-23 F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 25, 2020 02:14 UTC |
MOATAZEDI DAVIDDirector · See Remarks
|
GrantCommon Stock | 82,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-20-000047 · wf-form4_157991844635493.xml · nonDerivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,070 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 25, 2020 02:08 UTC |
Hau BosunDirector
|
GrantStock Option (Right to Buy) · Derivative | 23,458 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0001570562-20-000040 · wf-form4_157991810249418.xml · derivative · entry 1 Hau Bosun · CIK 0001730224 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,458 Underlying: Common Stock · 23,458 shares Expires 2030-01-23 F1 · derivative.exercise_date: The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 25, 2020 02:08 UTC |
Romine KristineDirector
|
GrantStock Option (Right to Buy) · Derivative | 23,458 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0001570562-20-000039 · wf-form4_157991807942005.xml · derivative · entry 1 Romine Kristine · CIK 0001730037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,458 Underlying: Common Stock · 23,458 shares Expires 2030-01-23 F1 · derivative.exercise_date: The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 25, 2020 02:07 UTC |
Malik VikramDirector
|
GrantStock Option (Right to Buy) · Derivative | 23,458 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0001570562-20-000036 · wf-form4_157991801048284.xml · derivative · entry 1 Malik Vikram · CIK 0001730123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,458 Underlying: Common Stock · 23,458 shares Expires 2030-01-23 F1 · derivative.exercise_date: The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 25, 2020 02:06 UTC |
Parschauer Karah HerdmanDirector
|
GrantStock Option (Right to Buy) · Derivative | 23,458 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0001570562-20-000034 · wf-form4_157991796400306.xml · derivative · entry 1 Parschauer Karah Herdman · CIK 0001677455 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,458 Underlying: Common Stock · 23,458 shares Expires 2030-01-23 F1 · derivative.exercise_date: The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 21:10 UTC |
AEON Biopharma, Inc.Former 10% Owner
|
OtherCommon Stock | 8,662,346 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-20-000010 · primary_doc.xml · nonDerivative · entry 1 AEON Biopharma, Inc. · CIK 0001622667 · Former 10% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to a Contribution Agreement dated January 8, 2020, by and between the Reporting Person (formerly known as Alphaeon Corporation) and Alphaeon 1 LLC ("Alphaeon"), on January 8, 2020, the Reporting Person contributed 8,662,346 shares of the Issuer to Alphaeon (the "Contribution"). The shares of the Issuer contributed to Alphaeon are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. At the time of the Contribution, Alphaeon was a wholly-owned subsidiary of the Reporting Person. Immediately after the Contribution, the Reporting Person distributed out all of the membership interests of Alphaeon to its stockholders. The Reporting Person is filing this exit Form 4 to report that it is no longer a beneficial owner of the Issuer's securities. Read SEC document |
| January 07, 2020 Filed Jan 9, 2020 00:37 UTC |
Avelar RuiSee Remarks
|
SaleCommon Stock | 39,442 | $10.71 | $422,281.83 |
DisclosureSEC source: 0001570562-20-000002 · wf-form4_157853021770409.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,802 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in the fourth quarter of 2019 and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. F2 · price: The shares were sold in multiple trades at prices ranging from $10.68 to $11.2016. The price reported above reflects the weighted average selling price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| December 10, 2019 Filed Dec 11, 2019 22:53 UTC |
Avelar RuiSee Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,020 | $0.00 Strike: $9.98 | $0.00 |
DisclosureSEC source: 0001570562-19-000164 · wf-form4_157610476734295.xml · derivative · entry 2 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,682 Underlying: Common Stock · 10,020 shares Expires 2028-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option was granted on January 6, 2018 for the right to buy 199,702 shares of common stock of the Issuer. The shares subject to the option vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 6, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. Read SEC document |
| December 10, 2019 Filed Dec 11, 2019 22:53 UTC |
Avelar RuiSee Remarks
|
Exercise / conversionCommon Stock | 10,020 | $9.98 | $99,999.60 |
DisclosureSEC source: 0001570562-19-000164 · wf-form4_157610476734295.xml · nonDerivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 20:30 UTC |
FARRELL PETER CDirector
|
GrantCommon Stock · Derivative | 26,163 | $0.00 Strike: $15.99 | $0.00 |
DisclosureSEC source: 0001570562-19-000113 · wf-form4_156339544054218.xml · derivative · entry 1 FARRELL PETER C · CIK 0001186102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,163 Underlying: Common Stock · 26,163 shares Expires 2029-07-15 F1 · derivative.exercise_date: The shares subject to the option will vest over a period of two years, with 1/2 of the shares subject to the option vesting annually on the anniversary of July 15, 2019. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 20:31 UTC |
Parschauer Karah HerdmanDirector
|
GrantCommon Stock · Derivative | 26,163 | $0.00 Strike: $15.99 | $0.00 |
DisclosureSEC source: 0001570562-19-000114 · wf-form4_156339545939626.xml · derivative · entry 1 Parschauer Karah Herdman · CIK 0001677455 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,163 Underlying: Common Stock · 26,163 shares Expires 2029-07-15 F1 · derivative.exercise_date: The shares subject to the option will vest over a period of two years, with 1/2 of the shares subject to the option vesting annually on the anniversary of July 15, 2019. Read SEC document |
| June 13, 2019 Filed Jun 14, 2019 21:59 UTC |
GILL DAVID NDirector
|
PurchaseCommon Stock | 2,000 | $13.65 | $27,300.00 |
DisclosureSEC source: 0001570562-19-000103 · wf-form4_156056397196003.xml · nonDerivative · entry 1 GILL DAVID N · CIK 0001106519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 23:52 UTC |
Malik VikramDirector
|
PurchaseCommon Stock | 1,298,701 | $19.25 | $24,999,994.25 |
DisclosureSEC source: 0001570562-19-000095 · wf-form4_155969235978393.xml · nonDerivative · entry 1 Malik Vikram · CIK 0001730123 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,298,701 F1 · shares: The acquisition of the shares of common stock referenced in this Form 4 was conducted in a private transaction between ALPHAEON Corporation ("ALPHAEON") and Strathspey Crown Holdings Group, LLC ("SCH"). SCH is the majority shareholder of ALPHAEON. The shares of common stock received by SCH are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. F2 · ownership.nature: The reported securities are directly owned by SCH and may be deemed beneficially owned by the Reporting Person as a Managing Partner of SCH. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 23:40 UTC Amendment |
AEON Biopharma, Inc.10% owner
|
SaleCommon Stock | 1,298,701 | $19.25 | $24,999,994.25 |
DisclosureSEC source: 0001078782-19-000500 · primary_doc.xml · nonDerivative · entry 1 Alphaeon Corp · CIK 0001622667 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,662,346 F1 · kind: The acquisition of the shares of common stock referenced in this Form 4 was conducted in a private transaction between ALPHAEON Corporation ("ALPHAEON") and Strathspey Crown Holdings Group, LLC ("SCH"). SCH is a majority shareholder of ALPHAEON. The shares of common stock received by SCH are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. F1 · shares: The acquisition of the shares of common stock referenced in this Form 4 was conducted in a private transaction between ALPHAEON Corporation ("ALPHAEON") and Strathspey Crown Holdings Group, LLC ("SCH"). SCH is a majority shareholder of ALPHAEON. The shares of common stock received by SCH are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. F1 · price: The acquisition of the shares of common stock referenced in this Form 4 was conducted in a private transaction between ALPHAEON Corporation ("ALPHAEON") and Strathspey Crown Holdings Group, LLC ("SCH"). SCH is a majority shareholder of ALPHAEON. The shares of common stock received by SCH are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 23:03 UTC |
AEON Biopharma, Inc.10% owner
|
SaleCommon Stock | 1,298,701 | $19.25 | $24,999,994.25 |
DisclosureSEC source: 0001078782-19-000499 · primary_doc.xml · nonDerivative · entry 1 Alphaeon Corp · CIK 0001622667 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,662,346 Read SEC document |
| May 31, 2019 Filed May 31, 2019 23:51 UTC |
SILVERNAIL LAUREN PSee Remarks
|
SaleCommon Stock | 2,612 | $13.53 | $35,352.11 |
DisclosureSEC source: 0001570562-19-000092 · wf-form4_155934669118868.xml · nonDerivative · entry 1 SILVERNAIL LAUREN P · CIK 0001225755 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,388 F1 · shares: Represents shares sold solely for the purpose of covering tax withholding obligations in connection with the vesting and settlement of certain restricted stock units held by the reporting person previously described in a Form 4 filed on May 31, 2018. F2 · price: The shares were sold in multiple trades at prices ranging from $13.5213 to $13.5355. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 29, 2019 Filed May 31, 2019 23:52 UTC |
Romine KristineDirector
|
PurchaseCommon Stock | 2,090 | $14.77 | $30,863.24 |
DisclosureSEC source: 0001570562-19-000093 · wf-form4_155934672639420.xml · nonDerivative · entry 1 Romine Kristine · CIK 0001730037 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 3,450 F1 · shares: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. F2 · price: The shares were purchased in multiple trades at prices ranging from $14.75 to $14.77. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 22, 2019 Filed May 22, 2019 23:04 UTC |
AEON Biopharma, Inc.10% owner
|
SaleCommon Stock | 290,518 | $19.25 | $5,592,471.50 |
DisclosureSEC source: 0001078782-19-000477 · primary_doc.xml · nonDerivative · entry 3 Alphaeon Corp · CIK 0001622667 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,961,047 F1 · kind: The disposition of an aggregate of 1,307,940 shares of common stock was made pursuant to a private transaction with certain of Alphaeon Corporation's existing noteholders who elected to receive payment of certain outstanding amounts under their notes due June 23, 2019 in the form of shares of common stock rather than cash. The shares of common stock received by the noteholders are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. Read SEC document |
| May 20, 2019 Filed May 22, 2019 19:12 UTC |
BLANK SIMONEDirector
|
PurchaseCommon Stock | 628,536 | $19.25 | $12,099,318.00 |
DisclosureSEC source: 0001570562-19-000088 · wf-form4_155856672795834.xml · nonDerivative · entry 1 BLANK SIMONE · CIK 0001366840 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 923,560 F1 · price: The acquisition of the shares of common stock referenced in this Form 4 was conducted in a private transaction between ALPHAEON Corporation ("ALPHAEON") and Dental Innovations BVBA ("DI"). DI holds certain notes issued by ALPHAEON. DI elected to receive payment from ALPHAEON of the outstanding amounts of the notes due in June 2019 in the form of shares of common stock rather than cash. The shares of common stock received by the Dental Innovations BVBA are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. F2 · ownership.nature: The reported securities are directly owned by DI and may be deemed beneficially owned by the Reporting Person as a shareholder of DI. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| May 20, 2019 Filed May 22, 2019 23:12 UTC |
Romine KristineDirector
|
PurchaseCommon Stock | 40,562 | $19.25 | $780,818.50 |
DisclosureSEC source: 0001570562-19-000089 · wf-form4_155856675911260.xml · nonDerivative · entry 1 Romine Kristine · CIK 0001730037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,909 F1 · price: The acquisition of the shares of common stock referenced in this Form 4 was conducted in a private transaction between ALPHAEON Corporation ("ALPHAEON") and the Reporting Person. The Reporting Person holds certain notes issued by ALPHAEON. The Reporting Person elected to receive payment from ALPHAEON of the outstanding principal and interest amounts of the notes due in June 2019 in the form of shares of common stock rather than cash. The shares of common stock received by the Reporting Person are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. Read SEC document |
| May 20, 2019 Filed May 22, 2019 23:04 UTC |
AEON Biopharma, Inc.10% owner
|
SaleCommon Stock | 1,017,422 | $19.25 | $19,585,373.50 |
DisclosureSEC source: 0001078782-19-000477 · primary_doc.xml · nonDerivative · entry 2 Alphaeon Corp · CIK 0001622667 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,251,565 F1 · kind: The disposition of an aggregate of 1,307,940 shares of common stock was made pursuant to a private transaction with certain of Alphaeon Corporation's existing noteholders who elected to receive payment of certain outstanding amounts under their notes due June 23, 2019 in the form of shares of common stock rather than cash. The shares of common stock received by the noteholders are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. Read SEC document |
| May 20, 2019 Filed May 22, 2019 23:04 UTC |
AEON Biopharma, Inc.10% owner
|
SaleCommon Stock | 4,000,000 | $19.25 | $77,000,000.00 |
DisclosureSEC source: 0001078782-19-000477 · primary_doc.xml · nonDerivative · entry 1 Alphaeon Corp · CIK 0001622667 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,268,987 Read SEC document |
| January 23, 2019 Filed Jan 25, 2019 20:18 UTC |
GILL DAVID NDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $16.19 | $0.00 |
DisclosureSEC source: 0001570562-19-000019 · wf-form4_154846548092960.xml · derivative · entry 1 GILL DAVID N · CIK 0001106519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2029-01-23 F1 · derivative.exercise_date: The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 23, 2019, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2019 Filed Jan 26, 2019 01:22 UTC |
Avelar RuiSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $16.19 | $0.00 |
DisclosureSEC source: 0001570562-19-000026 · wf-form4_154846575247503.xml · derivative · entry 1 Avelar Rui · CIK 0001432063 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2029-01-23 F1 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 23, 2019, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2019 Filed Jan 25, 2019 20:17 UTC |
HAYMAN ROBERTDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $16.19 | $0.00 |
DisclosureSEC source: 0001570562-19-000018 · wf-form4_154846544253494.xml · derivative · entry 1 HAYMAN ROBERT · CIK 0001269349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2029-01-23 F1 · derivative.exercise_date: The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 23, 2019, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.